Recurrent meningococcal infections in a patient with congenital C5 deficiency.

Department of General Internal Medicine, University Hospitals, K. U. Leuven, Belgium.
Acta clinica Belgica (Impact Factor: 0.59). 02/1993; 48(1):42-7.
Source: PubMed

ABSTRACT A congenital C5 deficiency was the cause of recurrent meningococcal disease in a 27-year-old man. The lack of serum bactericidal activity accounts for the higher incidence and the different course of Neisseria infections in patients with a deficiency of the late complement components. Early antibiotic treatment and vaccination with a capsular polysaccharide meningococcal vaccine (A,C,Y,W-135) should be considered.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The deficiency of complement C5 is rare and frequently associated with severe and recurrent infections, especially caused by Neisseria spp. We observed the absence of component C5 in the serum of 3 siblings from a Brazilian family with history of consanguinity. The patients had suffered from recurrent episodes of meningitis and other less severe infections. Sera from these patients were unable to mediate hemolytic activity either by the classical or alternative pathways and presented extremely low levels of C5 protein (1.3, 0.9 and 1.0 microg/ml-normal range: 45-190 microg/ml). Hemolytic activity could be restored by the addition of purified C5 to deficient serum. Sequencing of sibling C5 cDNA revealed a homozygous 153 bp deletion that corresponds precisely to exon 30. The parents carried the same deletion but only in one allele. Sequencing of the corresponding region in the genomic DNA revealed a C to G substitution within intron 30 and, most significantly, the substitution of GAG(4028) for GAA(4028) at the 3' end of exon 30 which is most likely responsible for skipping of exon 30. The resulting in-frame deletion in the C5 mRNA codes for a mutant C5 protein lacking residues 1289-1339. These residues map to the CUB and C5d domains of the C5 alpha chain. This deletion is expected to produce a non-functional and unstable C5 protein which is more susceptible to degradation.
    Molecular Immunology 05/2009; 46(10):2116-23. · 2.65 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Congenital deficiencies of complement system proteins are rare. A 4-year-old girl was admitted for meningitis. She had had repeated attacks of pneumococcal meningitis and otitis media at the age of 3 years. Analysis of cerebrospinal fluid showed that this meningitis was due to pneumococcal infection. Complement 3 and CH50 values of the proband and her brother were low, while her parents were normal. The patient was given polyvalent pneumococcal and anti-haemophilus vaccines plus ceftriaxone. Recovery was complete after 15 days of antibiotic therapy. This is the first description of a case of recurrent meningitis with C3 and CH50 deficiency in a Turkish family.
    The Indian Journal of Pediatrics 08/2002; 69(7):625-6. · 0.72 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: There is clear evidence for a host genetic component to meningococcal disease susceptibility with an increasing literature showing that genetic polymorphisms act as important determinants of both susceptibility and outcome. A large number of genes controlling susceptibility and outcome of meningococcal disease have been reported, but many of the associations have yet to be validated. A number of validated associations have been reported and these provide clues to key mechanisms influencing susceptibility and outcome. Identification of the genes involved in susceptibility and outcome of the disease may help in identifying those susceptible to the disease as well as providing important information on the immune pathways involved; and ultimately may identify new targets for therapeutic intervention.
    Vaccine 06/2009; 27 Suppl 2:B90-102. · 3.77 Impact Factor